ARTICLE | Distillery Therapeutics
Neurology
October 18, 2018 6:39 PM UTC
In silico, cell culture and mouse studies identified a GABRB2/GABRB3 positive allosteric modulator (PAM) that could help treat seizures. In silico screening of a small molecule library for structural ...
BCIQ Company Profiles